v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
ASSETS    
Cash and cash equivalents $ 8,309 $ 10,243
Marketable securities 5,952 7,942
Accounts receivable, net 9,885 9,086
Prepaids and other current assets 1,384 1,293
Inventory 6,117 6,926
Total current assets 31,647 35,490
Plant and equipment, net 8,211 8,630
Operating lease right-of-use assets 2,666 2,899
Corporate-owned life insurance ("COLI") asset 3,044 3,116
Intangible assets, net 5,442 5,645
Other long-term assets 534 612
Total assets 51,544 56,392
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)    
Accounts payable and accrued liabilities 7,220 8,959
Accrued wages and fringe benefits 7,870 7,813
Loan facility 46,139 42,984
Current non-qualified deferred compensation ("NQDC") liability 276 276
Contingent liability 3,000 0
Other current liabilities 2,166 2,645
Total current liabilities 66,671 62,677
Non-qualified deferred compensation liability 3,584 3,697
Contract liabilities 281 290
Operating lease liabilities, long term 1,981 2,135
Contingent liability, long-term 0 3,000
Warrant liabilities 2,193 1,243
Total liabilities 74,710 73,042
Commitments and contingencies (Note 11)
Stockholders' equity (deficit):    
Common stock, $0.0001 par value per share, 200,000,000 shares authorized, 30,776,689 and 30,571,662, shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 3 3
Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized, no shares issued or outstanding at March 31, 2026 and December 31, 2025 0 0
Company common stock held by the non-qualified deferred compensation plan (635) (1,293)
Additional paid-in capital 395,830 394,408
Accumulated other comprehensive income (loss) 648 (1,367)
Accumulated deficit (419,012) (408,401)
Total stockholders' equity (deficit) (23,166) (16,650)
Total liabilities and stockholders' equity (deficit) $ 51,544 $ 56,392